Soybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cells

  • Authors:
    • Eun-Kyung Yoon
    • Hyun-Kyoung Kim
    • Song Cui
    • Yong-Hoon Kim
    • Sang-Han Lee
  • View Affiliations

  • Published online on: January 12, 2012     https://doi.org/10.3892/ijmm.2012.887
  • Pages: 711-717
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glyceollins, produced to induce disease resistance responses against specific species, such as an incompatible pathogen Phytophthora sojae in soybeans, have the potential to exhibit anti-inflammatory activity in RAW 264.7 cells. To investigate the anti-inflammatory effects of elicited glyceollins via a signaling pathway, we studied the glyceollin signaling pathway using several assays including RNA and protein expression levels. We found that soybean glyceollins significantly reduced LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production, as well as the expression of inducible ΝΟ synthase (iNOS) and cyclooxygenase-2 (COX-2) via the suppression of NF-κB activation. Glyceollins also inhibited the phosphorylation of IκBα kinase (IKK), the degradation of IκBα, and the formation of NF-κB-DNA binding complex in a dose-dependent manner. Furthermore, they inhibited pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-18, but increased the generation of the anti-inflammatory cytokine IL-10. Collectively, the present data show that glyceollins elicit potential anti-inflammatory effects by suppressing the NF-κB signaling pathway in RAW 264.7 cells.

Introduction

It is now recognized that soybeans (Glycine max) and soybean foods, such as tofu and soymilk, can contribute to the better health of the elderly, young people, and pregnant woman (1). The soybean, a legume with a high protein content (~35–40%) is excellent at meeting dietary protein needs. Moreover, the importance of soybeans is proven by clinical and preclinical studies of hypocholesterolemia, diabetes, obesity, renal dysfunction and cardiovascular disorders (2,3). Soybeans contain many known components, such as phytoalexins, that are incredibly useful. Genistein, a soybean isoflavone, has been highlighted over the last few years as a potentially beneficial agent due to its wide-ranging effects on breast cancer, osteoporosis, coronary heart disease, diabetes and menopausal discomfort (46). Glyceollin, a phytoalexin found in soybeans and grapes, is produced as an immune response to pathogens (7). Glyceollins are isolated as a mixture of glyceollin I, II, and III (Fig. 1A), from germinated soybean from Rhyzopus sp. by an elicitor (8). These compounds have been investigated in relation to their anti-estrogenic activity through the inhibition of estrogen receptor α and β compared with well-known phytoestrogenic chemicals such as enterolactones and genistein (911). It also has been recognized that glyceollins can suppress human breast and ovarian carcinoma tumorigenesis (12) and may modulate potential estrogenic properties in the breast through an anti-estrogenic effect (13); however, researchers have yet to elucidate the molecular mechanisms of their biological activity.

On the other hand, it has been revealed that NF-κB plays a pivotal role in molecular inflammation by controlling the expression of various genes that encode pro-inflammatory cytokines, chemokines and inducible enzymes, such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), in mammalian immune cells (14). NF-κB is ubiquitously located in the cytoplasm of non-stimulated cells because of interactions with inhibitory proteins such as IκBs (15); but, it responds to pro-inflammatory stimuli, when IκBs are rapidly phosphorylated and degraded by the 26S proteasome (16,17), which results in the dissociation of free NF-κB dimers of p65 and p50, which translocate to the nucleus, and then activate the transcription of target genes. The IκBα kinase (IKK) complex contains two catalytic subunits: i) IKKα/β and ii) a regulatory subunit, IKKγ (1820). Activation of IKK is mediated by phosphorylation through various upstream kinases, such as the NF-κB-inducing kinase, NF-κB-activating kinase, Akt, and protein kinase Cζ, that are involved in cellular signaling in response to pro-inflammatory stimuli (21). Following activation, the NF-κB heterodimer activates the transcription of target genes, including the genes encoding the pro-inflammatory cytokines, such as interleukin (IL)-1, -6, -8, -18 and tumor necrosis factor-α (TNF-α) as well as iNOS, COX-2 and cell adhesion molecules (2224). In turn, the products regulated by NF-κB, such as TNF-α and IL-1β, also lead to the activation of NF-κB. This fact means that there is a complex regulatory loop that amplifies and perpetuates inflammatory responses; therefore, it has become a biological target for new types of anti-inflammatory treatment.

Based on this reason, we first hypothesized that glyceollins, overproduced by an elicitor Rhyzopus sp., can ameliorate immune cells by an NF-κB signaling pathway. To prove this hypothesis, we compared whether glyceollins have the potential to possess potent anti-inflammatory effects by inhibiting LPS-induced iNOS and COX-2 expression, as well as various inflammatory cytokines like TNF-α, IL-1β, IL-18 in RAW 264.7 cells. We further examined whether glyceollins inhibit the LPS-induced inflammation process by blocking an NF-κB signaling pathway.

Materials and methods

Materials and cell culture

LPS (purified from Escherichia coli 055:B5) was purchased from Sigma-Aldrich (St. Louis, MO) and fetal bovine serum (FBS) was purchased from Invitrogen (Carlsbad, CA). Antibodies against iNOS, COX-2, IKKα/β, NF-κB p65, IκBα and phospho-IκBα (Ser-32/36) were obtained from Cell Signaling Technology (Beverly, MA). RAW 264.7 cells were cultured in a RPMI-1640 medium supplemented with 10% of FBS, 2 mM of L-glutamine, 100 U/ml of penicillin, and 100 μg/ml of streptomycin at 37˚C in a 5% CO2 humidified incubator. We measured cell viability by counting, with a stain of 0.2% trypan blue solution.

Preparation of glyceollin mixture by elicitation

Glyceollins I, II and III (Fig. 1A, B and C) were semi-purified from elicited soybeans, with a slight modification, as previously described (8,11). In brief, we used soybeans (AGA, variant no. 3, a gift from KNU Soyventure, Daegu, Korea) that overproduce isoflavones to the rate of 10 mg/g of soybeans. The soybeans were elicited by a Rhyzopus sp. for de novo synthesis of glyceollins, which produced three kinds of isomers (data not shown). The cultures of Rhyzopus sp. were grown at 25˚C in a culture room on potato dextrose agar media and the inoculums were harvested after 5 days. We first washed the soybeans by dipping in a 65% ethanol solution for 1 min; thereafter, we washed them with deionized water before the soaking process. Soybean seeds were soaked in sterile, deionized water for 6 h, and then placed into a Sanyo MLR-351H growth chamber (Carlsbad, CA). After saturation with distilled water, the seeds were cut into 4 pieces by a knife. A spore suspension (100 μl) of Rhyzopus sp. was dispersed on the cut surfaces of the seeds. The seeds (20 g) were incubated at 26˚C for 4 days, extracted with 50 ml of 80% (v/v) ethanol for 1 h, then cooled and centrifuged at 20,000 × g for 10 min. The extracts were filtered by a membrane filter (0.45 μm) from Sartorius (Aubagne Cedex, France). Each crude extract was freeze-dried and dissolved in dimethyl sulfoxide. The extract was 100 μg/ml, and was used for further purification. For purification, we used a high-performance liquid chromatography system, the HPLC, PerkinElmer Series 200 (Waltham, MA). A Brownlee Choice C18 (150×4.6 mm) reverse-phase column and guard column were used. The injection volume and column temperature were 10 and 30 μl, respectively. Detection was monitored at 260 and 285 nm, and the flow rate was 1.0 ml/min at the following solvent condition (A, acetonitrile, B, 1% acetate in water; 0 to 45% A for 10.2 min; 45 to 90% A for 6 min, holding at 90% A for 3.6 min). The glyceollins were separated by thin-layer chromatography (TLC) for use in further experiments because the concentration was low and the amounts that we needed were small. The glyceollin phase was separated by open-column chromatography (OCC). A methanolic extract was fractionated on a Silica gel-60 (<0.063 mm: 0.063 mm, 8:2) developed in methylene chloride:methanol (97–99:1–3, v/v) solution. A sample of OCC extract was fractionated on aluminum-backed Silica gel-60 TLC plates developed in hexane:acetone (4:1.5, v/v). Glyceollins were visualized with 20% aqueous sulfuric acid spray reagent, and UV light at 254 nm. A single glyceollin band (Rf=0.2) was confirmed by a standard glyceollin, and further purified by preparative TLC. The concentration of glyceollin isomers in the fraction was up to ~90% as analyzed by preparative HPLC. The relative ratio of glyceollin I, II and III in the fraction was 17:2:1. Thereafter, we designated the fraction as glyceollins.

Cell viability assay

Cell viability was measured by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (25). Cells were seeded on 96-well plates at a concentration of 5×104 cells/well. After seeding, cells were incubated with MTT solution (1 mg/ml) for 2 h. The medium was discarded and the formazan product was solubilized with dimethyl sulfoxide. Viability was assessed by measuring absorbance at 570 nm with a Bio-Rad microplate reader (Hercules, CA).

Nitrite quantification

RAW 264.7 cells were treated with 1 μg/ml LPS plus sample for 16 h. Nitric oxide synthesis can be determined by assaying nitrite in the culture supernatant because nitrite is a stable reaction product of NO (26). Briefly, cell-free culture media were reacted with a 1:1 mixture of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride and 2.5% phosphoric acid) at room temperature for 10 min. The OD of the assay sample was measured spectrophotometrically at a wavelength of 570 nm. Nitrite concentration was calculated from a standard curve prepared using NaNO2 under the same assay conditions.

Western immunoblot analysis

Proteins were separated by SDS-PAGE and immunoblotted onto a nitrocellulose membrane in a buffer containing 20% methanol, 25 mM of Tris, and 192 mM of glycine, as described elsewhere (27). The membranes were then blocked with 5% non-fat dry milk and incubated with the primary antibody overnight. Subsequently, membranes were washed in Tween-Tris buffer saline (TTBS), incubated for 4 h with horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit (1:4,000) antibodies, and finally developed using an enhanced ECL system (KPL Inc., Gaithersburg, MD). The membranes were then reprobed with a β-actin antibody as a control.

Reverse transcription-polymerase chain reaction

Total-RNA was extracted from RAW 264.7 cells using an easy-BLUE total-RNA extraction kit from Intron Biotechnology (Sungnam, Korea) according to the manufacturer's protocols and was quantified by measuring absorbance at 260 nm. RNA was reverse-transcribed using 2.5 μM oligo(dt) primers, 1 mM dNTPs, and Moloney murine leukemia virus (MMLV) reverse transcriptase (Promega, Madison, WI), and the resulting cDNAs were amplified with SuperTherm DNA polymerase SR Product (Kent, UK). β-actin primers were used to standardize the amount of RNA in each sample. PCR products were resolved on 1% agarose gels and visualized by ethidium bromide staining (28).

Measurement of prostaglandin E2 production

RAW 264.7 cells were subcultured in 6-well plates treated with the indicated dose of glyceollins for 2 h in the presence or absence of LPS (1 μg/ml) for 16 h (29). The culture media was collected for determination of prostaglandin E2 (PGE2) concentration by an enzyme immunoassay kit from Cayman (Ann Arbor, MI).

Nuclear extracts

RAW 264.7 cells were incubated with glyceollins and LPS as indicated (30). The cells were harvested in PBS containing 2% serum, washed twice with ice-cold PBS, and resuspended in 500 μl of buffer A (10 mM of HEPES, pH 7.9, 5 mM of MgCl2, 10 mM of KCl, 1 mM of ZnCl2, 0.2 mM of EGTA, 1 mM of Na3VO4, 10 mM of NaF, 0.5 mM of dithiothreitol, 0.5 mM of PMSF and protease inhibitors). After the cells had been incubated on ice for 10 min and lysed by adding 50 μl of 20% Nonidet P-40, to a final concentration of 2%, their nuclei were harvested by centrifugation. The nuclear pellets were then resuspended in 60 μl of extraction buffer (10 mM HEPES, pH 7.9, 5 mM MgCl2, 300 mM NaCl, 0.2 mM EGTA, 25% glycerol, 1 mM Na3VO4, 10 mM NaF, 0.5 mM dithiothreitol, 0.5 mM PMSF and protease inhibitors), and incubated on ice for 15 min. Nuclear debris was then removed by centrifugation (13,000 rpm, 10 min), and the nuclear extracts were subjected to gel shift analysis. Protein concentrations were determined using a Bradford method (31).

Electrophoretic mobility shift assay

RAW 264.7 cells, in 10-cm diameter dishes (107 cells/dish), were pretreated with or without glyceollins for 2 h and then incubated with LPS (1 μg/ml) for 16 h. For the gel shift assay, a consensus sequence for the NF-κB DNA binding site, sc-2505 from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), was used. The mutant binding sequence for NF-κB was identical to sc-2505 except for a G→C substitution in the NF-κB-DNA binding motif (sc-2511, Santa Cruz Biotechnology, Inc.). Beforehand, the NF-κB probe was biotin-end labeled by the biotin 3′ end DNA labeling kit from Thermo Scientific Pierce (Rockford, IL). Briefly, EMSA binding reactions were performed by incubating 20 μg of nuclear extract with the annealed oligos with the LightShift EMSA kit from Thermo Scientific Pierce, according to the manufacturer's instructions. The reaction mixture was subjected to electrophoresis on a 4% native gel in a 0.5xTBE buffer. After transfer, the membrane was immediately cross-linked for 15 min on a UV transilluminator equipped with 312 nm bulbs. A chemiluminescence detection method utilizing a luminol/enhancer solution and a stable peroxide solution from Thermo Scientific Pierce was used as described by the manufacturer's manual, and the membranes were exposed to X-ray films for 2–5 min before developing (32).

Statistical analysis

Statistical differences between mean values ± SD were determined by the Dunnett's multiple range test. The significance was set at P<0.05 (33).

Results

Effect of glyceollins on cell viability

To examine whether glyceollins exhibit cytotoxicity in cells, we first measured whether glyceollins affect cell proliferation in RAW 264.7 cells. The result showed that, at concentrations up to 100 μM, glyceollins had no toxic effect on cell viability (Fig. 1A). Major and/or minor fractions did not have any morphological changes in microscopic observation (data not shown). Therefore, we decided to investigate whether glyceollins have potential in reducing iNOS and COX-2 expressions, which could be a landmark for the assessment of molecular inflammation.

Effects of glyceollins on NO production and expression of iNOS in LPS-stimulated RAW 264.7 cells

To assess the inhibitory effect of glyceollins on LPS-induced NO production in RAW 264.7 cells, the cells were treated with LPS (1 μg/ml) for 16 h after treatment in the presence or absence of glyceollins (0.1, 1, 10 or 50 μM) for 2 h. The amount of nitrite, a stable metabolite of NO, was used as the indicator of NO production in the medium. During the 16 h of incubation, RAW 264.7 cells produced up to 6.4±0.02 μM of nitrite in the resting state. When LPS (1 μg/ml) was added, NO production was dramatically increased up to 56.2±0.01 μM (Fig. 1B). In this condition, adding glyceollins inhibited LPS-induced NO production in a concentration-dependent manner corresponding to 10.6 and 58.7% inhibition at 0.1 and 50 μM, respectively (Fig. 1C). To further investigate whether the inhibitory effect of glyceollins on NO production was associated with the inhibition of corresponding gene expression, the protein and mRNA expressions of iNOS were determined by semi-quantitative RT-PCR and western blot analysis, respectively. In unstimulated RAW 264.7 cells, the iNOS mRNA and protein expressions were almost undetectable (Fig. 1D, first bands of each set); however, LPS treatment augmented the protein and mRNA expressions of iNOS remarkably; pretreatment of the cells with different concentrations of glyceollins also dramatically reduced LPS-induced iNOS mRNA and protein expressions in a concentration-dependent fashion (Fig. 1D, compare the second and sixth bands of each set at 0 to 50 μM). The intensity was a 5- and 12.5-fold decreased compared with that of LPS-treated cells. The data suggest that glyceollins can downregulate LPS-induced iNOS expression at the transcription level.

Effects of glyceollins on PGE2 production and COX-2 expression in LPS-stimulated RAW 264.7 cells

To examine whether glyceollins inhibit PGE2 production, the cells were pre-incubated with glyceollins for 2 h and then activated with 1 μg/ml of LPS for 16 h. As shown in Fig. 2A, unstimulated RAW 264.7 cells mildly decreased PGE2 production when compared with treatment with glyceollins alone. In Fig. 2B, LPS induced a 5.2-fold increase in the biosynthesis of PGE2 as compared with untreated cells, but glyceollins strongly inhibited the production of PGE2 in a dose-dependent manner. Because the biosynthesis of PGE2 is catalyzed by COX-1 and COX-2 enzymes, we next measured the effect of glyceollins on LPS-induced COX-2 activities. We also detected that glyceollins inhibited the COX-2 mRNA and protein expressions in a dose-dependent manner (Fig. 2C, 5- and 2.5-fold, respectively). The data suggest that glyceollins can downregulate LPS-induced COX-2 expression at the transcription level. Inhibition of COX-2 expression by glyceollins was responsible for the decrease of PGE2 production.

Effects of glyceollins on LPS-induced TNF-α, IL-1β, IL-18 and IL-10 mRNA expression

Glyceollins were found to inhibit the pro-inflammatory mediators, such as NO and PGE2, most potently. Therefore, to test whether glyceollins could effectively for regulate inflammatory and anti-inflammatory cytokines in RAW 264.7 cells, we examined the mRNA levels of TNF-α, IL-1β, IL-18 and IL-10 by RT-PCR. Though IL-1β mRNA expression was only slightly inhibited in a dose-dependent manner (Fig. 3), TNF-α and IL-18 mRNA expression was significantly reduced by pretreatment of RAW 264.7 cells with glyceollins (0.1, 1, 10 or 50 μM) (Fig. 3). In contrast, in terms of the anti-inflammatory cytokines, the ability of glyceollins to induce IL-10 increased up to 38±0.5% in the LPS-activated RAW 264.7 cells (Fig. 3), while that of β-actin was not altered.

Inhibitory effects of glyceollins on IκBα kinase activation and IκBα phosphorylation

Because the phosphorylation of IKK, and its subsequent phosphorylation of IκBα, are key signals for the activation of NF-κB, we examined the effect of glyceollins on LPS-induced phosphorylation of IKK and the degradation of IκBα protein by western blot analysis. A time-course experiment showed that IκBα in the cytoplasm was almost completely degraded within 10 min, and that it recovered at 30 min, after LPS (1 μg/ml) stimulation (Fig. 4A). Pretreatment with glyceollins prevented the induced degradation of IκBα protein at 5 and 15 min; the recovery of IκBα, which is under the control of NF-κB, was also suppressed (data not shown). IκBα phosphorylation was also examined by western blot analysis. As shown in Fig. 4A, the phosphorylated form of IκBα was hardly detectable in the resting RAW 264.7 cells; however, upon exposure to LPS (1 μg/ml) alone for 10 min, IκBα phosphorylation was initiated. At 30 min after LPS stimulation, pretreatment of glyceollins moderately inhibited LPS-mediated IκBα phosphorylation (Fig. 4A). Because IKK-α and β are the upstream kinases of IκB in the NF-κB signaling pathway and are activated via phosphorylation, we examined the effect of glyceollins on LPS-induced IKKα/β activations by western blot analysis using an a phospho-specific IKKα/β antibody. RAW 264.7 cells were pretreated with glyceollins (50 μM) for 2 h and then stimulated with LPS (1 μg/ml) for various courses of time. As shown in Fig. 4A, LPS was found to strongly induce IKKα/β phosphorylation, whereas glyceollin pretreatment significantly inhibited this phosphorylation. These findings indicate that glyceollins suppressed IKK and IκBα phosphorylation in LPS-induced RAW 264.7 cells.

Effects of glyceollins on LPS-induced NF-κB activation

To investigate whether glyceollins affect the DNA binding ability of the NF-κB complex in the RAW 264.7 cells, we performed an electrophoretic mobility shift assay (EMSA). RAW 264.7 cells were pretreated with 0.1–50 μM of glyceollins for 2 h, and then the cells were stimulated with LPS for 16 h. RAW 264.7 cells with LPS strongly induced the DNA binding activity of NF-κB. In contrast, pretreatment with glyceollins significantly suppressed the induced the DNA-binding activity of NF-κB by LPS in a dose-dependent manner (Fig. 4B). Taken together, the above findings indicate that glyceollins suppress NO production as well as expressions of iNOS, COX-2, TNF-α, IL-1β and IL-18, at least in part via an NF-κB-dependent mechanism.

Discussion

Phytoalexin is now a well-documented self-defense biomaterial that is produced by plants, and plays a critical role in exhibiting various biological events in animal and plant tissues (7,8). Recently, it has been revealed that these compounds have potential in ameliorating antioxidant, antifungal and antidiabetic activities in vitro and in vivo (34). In soybeans, glyceollin, a family of lipophilic phytoalexins, as a secondary metabolite, is often accumulated at sites infected by pathogens like Phytophthora sojae to inhibit their growth (35). The compound is also known to be induced by countless stress factors or physical stimuli, such as freezing, UV light exposure, and/or microbes (34,36). Because bean, grape, and sunflower seeds have been known to possess various biological activities, many researchers have been focused on the isolation and purification of active compounds; but this process was not convenient to obtain enough material for experimentation. The present approach of obtaining glyceollins deserves further study, especially since the connection between the signaling pathways and glyceollins has not been discovered so far. Although glyceollin and/or their derivatives have been investigated in relation to their biological activities, including anti-estrogenic activity (913), their precise mechanisms of signaling are scarcely understood at the present time.

Therefore, in the present study we first hypothesized that glyceollins effectively protect against the generation of pro-inflammatory mediators, specifically, NO and PGE2, through the inhibition of iNOS and COX-2 expression levels, respectively. We subsequently confirmed that the inhibition of NO production is concurrent with the suppression of iNOS expression at the mRNA and protein levels as shown by RT-PCR and western blot analysis (Fig. 1D). In addition, we investigated another mediator of inflammation, COX-2, which acts as a rate-limiting enzyme in the synthesis of prostaglandin-like PGE2. In line with our prediction, glyceollins strongly inhibited PGE2 production and COX-2 mRNA and protein levels (Fig. 2). TNF-α plays a key role in the induction of various genes, such as COX-2, through the activation of NF-κB by T cells and macrophages (37). To alleviate the inflammatory response in LPS-stimulated macrophages, it is also necessary to hamper IL-1β and IL-18 production, which both enhance the body's inflammatory response. These cytokines are known to be increased through the NF-κB signaling pathway (3840). On the other side, IL-10 is a representative anti-inflammatory cytokine and has pleiotropic effects during the immunoregulation and inflammation processes in various immune cells (41). As shown in our data, glyceollins are effective for inflammation-related cytokines such as TNF-α, IL-1β, IL-18 or IL-10 expression using RT-PCR (Fig. 3). We clearly found that glyceollins are potent inhibitors of TNF-α production by RAW 264.7 macrophages with ~10 μM of an IC50 value; this is similar to luteolin and quercetin, which have been the most potent natural products so far at inhibiting TNF-α release, with IC50 values of <1 μM (42) and <5 μM, respectively (data not published).

It is well-recognized that NF-κB, a universal transcription factor, plays a pivotal role in the various soluble pro-inflammatory gene expressions and leukocyte adhesion molecules (38,39). As a key step to activate NF-κB functions, studies have been focused on the activation of the IKK complex over the last several years. Many natural phytochemicals, such as luteolin, quercetin, and resveratrol, suppress LPS-induced iNOS and COX-2 expressions as well as inflammatory cytokine expressions in macrophages by inhibiting the NF-κB signaling pathway, such as phosphorylation of IKK, degradation of IκBα, and nuclear translocation of NF-κB (43,44). Because the glyceollin-mediated signaling pathway can provide us with useful information on the function of the agent, we next studied the NF-κB-mediated signaling pathway in RAW 264.7 cells. In our study, western blot analysis revealed that glyceollins inhibited the LPS-induced phosphorylation of IKK, a series of phosphorylations of IκBα and degradation of p-IκB (Fig. 4A). We also demonstrated that glyceollins inhibit LPS-induced NF-κB in RAW 264.7 cells by performing EMSA. Pretreatment with glyceollins significantly suppressed the induced DNA-binding activity of NF-κB by LPS in a dose-dependent manner (Fig. 4B). Therefore, the above results suggest that glyceollins suppress the inflammation reaction through an NF-κB-dependent signal transduction pathway. Up to now, no data regarding a glyceollin-mediated signaling pathway has been investigated. As a result, our data have the potential to help develop prophylactic and therapeutic anti-inflammatory agents that are both safe and original. Further study of the overall signal transduction pathway promises to be rewarding because the inhibitory mechanism by glyceollins can provide new data for anti-inflammatory therapies.

This study describes a signaling pathway of the anti-inflammatory effects elicited glyceollins. Our results suggest that the glyceollins obtained from soybeans may exhibit increased anti-inflammatory effects. Glyceollins have an appreciable inhibitory activity against the overproduction of inflammatory mediators such as iNOS, COX-2 and various cytokines. Not only can they be used to investigate their effects in various biological areas, but if we uncover the precise mechanisms by glyceollins in immune cells, they can also be used to prevent immune diseases. Use of traditionally fermented soybean products may prove rewarding because we can naturally obtain their high levels of phytoalexins, such as glyceollins.

Acknowledgements

This study was supported by a grant by the Ministry of Knowledge and Economy, Republic of Korea, under contract no. 70000385 (Y.-H.K.), and partially by a Kyungpook National University Research Fund (S.-H.L.).

Abbreviations:

NO

nitric oxide

iNOS

inducible nitric oxide synthase

COX-2

cyclooxygenase-2

PGE2

prostaglandin

IKK

IκBα kinase

TNF

tumor necrosis factor

IL

interleukin

References

1 

N TorresI Torre-VillalvazoAR TovarRegulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disordersJ Nutr Biochem17365373200610.1016/j.jnutbio.2005.11.00516481155

2 

TB NgXJ YeJH WongEF FangYS ChanW PanXY YeSC SzeKY ZhangF LiuHX WangGlyceollin, a soybean phytoalexin with medicinal propertiesAppl Microbiol Biotechnol5890599068201121336922

3 

WO SongOK ChunI HwangHS ShinBG KimKS KimSY LeeD ShinSG LeeSoy isoflavones as safe functional ingredientsJ Med Food10571580200710.1089/jmf.2006.062018158825

4 

CD AllredKF AllredYH JuTS GeoppingerDR DoergeWG HelferichSoy processing influences growth of estrogen dependent breast cancer tumorsCarcinogenesis2516491657200510.1093/carcin/bgh17815131010

5 

M MessinaSoy foods and soybean phytoestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT)Eur J Cancer367177200010.1016/S0959-8049(00)00233-111056326

6 

DS LeeSH LeeGenistein, a soy isoflavone, is a potent alpha-glucosidase inhibitorFEBS Lett5018486200110.1016/S0014-5793(01)02631-X11457461

7 

P JeandetAC Douillet-BreuilR BessisS DebordM SbaghiM AdrianPhytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolismJ Agric Food Chem5027312741200210.1021/jf011429s11982391

8 

SM BouéCH CarterKC EhrlichTE ClevelandInduction of the soybean phytoalexins coumestrol and glyceollin by AspergillusJ Agric Food Chem82167172200010888516

9 

ME BurowSM BouéBM Collins-BurowLI MelnikBN DuongCH Carter-WientjesS LiTE WieseTE ClevelandJA McLachlanPhytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor α and βJ Clin Endocrinol Metab8617501758200111297613

10 

GN NikovNE HopkinsS BoueWL AlworthInteractions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formationEnviron Health Perspect108867872200010.1289/ehp.0010886711017892

11 

HJ KimHJ SuhJH KimS ParkYC JooJS KimAntioxidant activity of glyceollins derived from soybean elicited with Aspergillus sojaeJ Agric Food Chem581163311638201010.1021/jf102829z21033668

12 

VA SalvoSM BouéJP FonsecaS ElliottC CorbittBM Collins-BurowTJ CurielSK SrivastavBY ShihCC WientjesAntiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesisClin Cancer Res1271597164200610.1158/1078-0432.CCR-06-142617145841

13 

CE WoodTB ClarksonSE ApptAA FrankeSM BouéME BurowT McCoyJM ClineEffects of soybean glyceollins and estradiol in postmenopausal female monkeysNutr Cancer567481200610.1207/s15327914nc5601_1017176220

14 

T HenkelU ZabelE FanningPA BaeuerleIntramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunitCell681121113319921547506

15 

M KarinM DelhaseThe IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalingSemin Immunol1285982000

16 

S GhoshM KarinMissing pieces in the NF-κB puzzleCell109SupplS81S962002

17 

MS HaydenS GhoshSignaling to NF-κBGenes Develop18219522242004

18 

E ZandiM KarinBridging the gap composition, regulation and physiological function of the IκB kinase complexMol Cell Biol1945474551199910373503

19 

T WangX ZhangJJ LiThe role of NF-κB in the regulation of cell stress responsesInt Immunopharmacol2150915202002

20 

F YangE TangK GuanCY WangIKK plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharideJ Immunol17056305635200310.4049/jimmunol.170.11.563012759443

21 

HL PahlActivators and target genes of Rel/NF-κB transcription factorsOncogene18685368661999

22 

JT WuJG KralThe NF-κB/IκB signaling system: a molecular target in breast cancer therapyJ Surg Res1231581692005

23 

R LangRL RutschmanDR GreavesPJ MurrayAutocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoterJ Immunol16834023411200210.4049/jimmunol.168.7.340211907098

24 

LL CheshireAS Baldwin JrSynergistic activation of NF-κB by tumor necrosis factor α and interferon via enhanced IκBα degradation and de novo IκBα degradationMol Cell Biol17674667541997

25 

J KlostergaardA rapid extremely sensitive, quantitative microassay for cytotoxic cytokinesLymphokine Res430931719853876491

26 

CJ LowensteinEW AlleyP RavalAM SnowmanSH SnyderSW RussellWJ MurphyMacrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharideProc Natl Acad Sci USA9097309734199310.1073/pnas.90.20.97307692452

27 

CH ParkDY NamHU SonSR LeeHJ LeeJC HeoTY ChaJH BaekSH LeePolymer fraction of Aloe vera exhibits a protective activity on ethanol-induced gastric lesionsInt J Mol Med275115182011

28 

MH PanYH ChangML TsaiCS LaiSY HoV BadmaevCT HoPterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophagesJ Agric Food Chem5675027509200810.1021/jf800820y18656926

29 

N KusunokiK KitaharaF KojimaN TanakaK KanekoH EndoT SuguroS KawaiAdiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblastsArthritis Rheum6216411649201010.1002/art.2745020222108

30 

KS AhnEJ NohHL ZhaoSH JungSS KangYS KimInhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cellsLife Sci7623152328200510.1016/j.lfs.2004.10.04215748625

31 

MM BradfordA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem72248254197610.1016/0003-2697(76)90527-3942051

32 

I AndújarMC RecioT BacelliRM GinerJL RíosShikonin reduces oedema induced by phorbol ester by interfering with IκBα degradation thus inhibiting translocation of NF-κB to the nucleusBr J Pharmacol160376388201020423347

33 

M SonA KimJ LeeCH ParkJC HeoHJ LeeSH LeeEthanol extract of Lycoris radiata induces cell death in B16F10 melanoma via p38-mediated AP-1 activationOncol Rep244734782010

34 

JD PaxtonBiosynthesis and accumulation of legume phytoalexinsMycotoxins and PhytoalexinsRP SharmaDK SalunkheCRC PressBoca Raton4854991991

35 

LI Rivera-VargaAF SchmitthennerTL GrahamSoybean flavonoid effects on metabolism by Phytophthora sojaePhytochemistry32851857199310.1016/0031-9422(93)85219-H

36 

S FengCL SawYK LeeD HuangFungal-stressed germination of black soybeans leads to generation of oxooctadecadienoic acids in addition to glyceollinsJ Agric Food Chem5585898595200710.1021/jf071673517892258

37 

E AndreakosTargeting cytokines in autoimmunity: new approaches, new promiseExpert Opin Biol Ther3435447200310.1517/14712598.3.3.43512783612

38 

F ChenLM DemersX ShiUpstream signal transduction of NF-κB activationCurr Drug Targets Inflamm Allergy11371492002

39 

D KulmsT SchwarzNF-κB and cytokinesVitam Horm742833002006

40 

K SukS KimU KimRegulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-κB pathway in the regulatory processesImmunol Lett777985200111377701

41 

S MocellinMC PanelliE WangD NagorsenFM MarincolaThe dual role of IL-10Trends Immunol243643200310.1016/S1471-4906(02)00009-1

42 

AT PaulVM GohilKK BhutaniModulating TNF-α signaling with natural productsDrug Discov Today117257322006

43 

DM MinichJS BlandDietary management of the metabolic syndrome beyond macronutrientsNutr Rev66429444200810.1111/j.1753-4887.2008.00075.x18667004

44 

PA RuizD HallerFunctional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cellsJ Nutr136664671200616484540

Related Articles

Journal Cover

April 2012
Volume 29 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yoon E, Kim H, Cui S, Kim Y and Lee S: Soybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cells. Int J Mol Med 29: 711-717, 2012
APA
Yoon, E., Kim, H., Cui, S., Kim, Y., & Lee, S. (2012). Soybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cells. International Journal of Molecular Medicine, 29, 711-717. https://doi.org/10.3892/ijmm.2012.887
MLA
Yoon, E., Kim, H., Cui, S., Kim, Y., Lee, S."Soybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cells". International Journal of Molecular Medicine 29.4 (2012): 711-717.
Chicago
Yoon, E., Kim, H., Cui, S., Kim, Y., Lee, S."Soybean glyceollins mitigate inducible nitric oxide synthase and cyclooxygenase-2 expression levels via suppression of the NF-κB signaling pathway in RAW 264.7 cells". International Journal of Molecular Medicine 29, no. 4 (2012): 711-717. https://doi.org/10.3892/ijmm.2012.887